Connect with us

International

Top Growth Stocks To Watch In June 2021

Growth stocks appear to have staged a comeback, do you have these names on your list?
The post Top Growth Stocks To Watch In June 2021 appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

Are These Growth Stocks Still Worth Investing In Right Now?

Growth stocks have been one of the favorite choices for investors looking to allocate their hard-earned money. This is mainly because they have been providing outsized gains compared to the broader market, at least for the past two decades. There are plenty of top growth stocks that are experiencing explosive growth in the current volatile stock market environment. But I think we all can agree that growth stocks that are delivering impressive results today and can continue to be great long-term investments can be quite hard to find.

The hallmark of the best growth stocks to buy may typically include improving fundamentals and a history of bullish trading activity in the shares. With rising inflation risks and investors rotating their portfolios towards value stocks, picking a growth stock to buy is becoming increasingly difficult. Nevertheless, to help safeguard your investment, looking at stocks with good growth prospects and justifiable valuations could be a great way to start. That said, do you have the following growth stocks on your list in the stock market today?

Growth Stocks To Buy [Or Avoid] Right Now

  1. Fastly (NYSE: FSLY)
  2. Zscaler (NASDAQ: ZS)
  3. BioNTech (NASDAQ: BNTX)
  4. Palantir Technologies (NYSE: PLTR)
  5. ViacomCBS Corporation (NASDAQ: VIAC)

Fastly

Fastly was one hot stock to watch in 2020. The company is a key player in the content delivery network (CDN) space. Arguably, the real trick up Fastly’s sleeves are its edge computing capabilities. But the reason many investors could be paying attention to Fastly right now is that FSLY stock has fallen too fast and too hard for a company with double-digit growth.

From its most recent quarterly report, Fastly’s revenue came in 35% higher year-over-year to $84.9 million, which was only slightly short of estimates at $85.1 million. While the net retention rate was slightly lower than its previous quarter, its total customer count actually increased from 2,084 in the fourth quarter to 2,207.

Sure, the company may have missed top and bottom-line estimates, but the difference was only marginal. If you ask me, the sell-off seems overdone to me. If you believe that the trend that appeared last year is likely to become permanent, FSLY stock is increasingly looking like an opportunistic bet to me after the sell-off.

[Read More] 5 Top Health Care Stocks To Watch Ahead Of June 2021

Zscaler

Next on the list, we have a top cybersecurity stock Zscaler Inc. Zscaler is a cloud security company that has been trending in the stock market this year. ZS stock is another top growth stock that has been on investors’ radars as of late. The company’s stock price surged more than 12% on Wednesday’s trading.

best cybersecurity stocks to buy (ZS stock)

This came after the company delivered strong third-quarter financial results. In detail, the company’s revenue came in 60% higher year-over-year to $176.4 million. The strong growth came amid the backdrop of more businesses migrating their operations to the cloud.

According to the CEO, Jay Chaudhry, Zscaler’s Zero Trust Exchange platform is helping customers realize their digital transformation goals and architect for the new normal of the work-from-anywhere economy. Even as more people begin to return to their work offices, the transition to the cloud will likely continue. Considering that cyberattacks are increasing in scale and sophistication, could ZS stock continue its momentum in the coming quarters? 

Read More

BioNTech

BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and infectious diseases. Most people get to know the company through its partnership with Pfizer (NYSE: PFE) in developing the COVID-19 vaccine. From its first-quarter report, revenue came in at $2.49 billion in the first quarter. This result reflected a huge 7,300% increase from the prior-year period. And that’s not all, the company’s bottom line also improved dramatically. 

top biotech stocks to watch (BNTX stock)

It’s no secret that its recent quarterly reports have been all about its vaccine candidate BNT162b2. The company currently shares its net profits equally with Pfizer for sales of the vaccine globally, except in China. The company said that it had supplied more than 450 million doses of its COVID-19 vaccine to 91 countries or territories as of May 6, with signed agreements for more than 1.8 billion doses in 2021.

The estimated revenue from COVID-19 vaccine deliveries, based on the currently signed contracts, is €12.4 billion. With this kind of revenue growth, it’s not surprising why many would consider BNTX stock to be a top growth stock in the stock market today.

[Read More] Hot Stocks To Buy Now? 5 Cyclical Stocks To Watch

Palantir Technologies

Palantir Technologies is a developer of software and analytics tools for the defense industry and large corporations. For those unfamiliar, the company’s Gotham platform enables government customers to identify patterns hidden deep within datasets, ranging from signals from intelligence sources to reports from confidential informants. Now you might think these sound more like a company with fictional software. But fret not, Palantir has managed to deliver. 

best tech stocks (PLTR stock)

The company reported its first-quarter earnings this week. From the report, revenue came in 49% higher year-over-year to $341 million. Besides, cash generation also improved dramatically. More importantly, the management expects revenue to increase 43% to $360 million in the second quarter. We are looking at a company with disruptive technology and a sizable addressable market.

For the long term, Palantir believes it can provide over 30% revenue growth this year and for the next four years. Considering its growth momentum, would PLTR stock be an ideal investment for investors with a long-term horizon?

[Read More] 5 Electric Vehicle Stocks To Watch After Ford Boosts Spending On EVs

ViacomCBS Corporation

Viacom is a diversified multinational mass media conglomerate that is headquartered in New York City. In essence, the company delivers premium content to audiences across traditional and emerging platforms worldwide. Following the failure of Archegos Capital Management, VIAC stock shed more than half of its value in a matter of days. Now with acquisition rumors amid an intensifying streaming war, ViacomCBS is in the headlines again.

top entertainment stocks (VIAC stock)

Last week, Bank of America issued a double upgrade on the company and raised its price target. Their reasons- relatively low positions among streaming companies and its sizable content library making it an attractive acquisition target. From its latest fiscal report, revenue grew by 65% year-over-year, fueled by strong increases in user and product monetization. Total revenue for the quarter was a whopping $7.41 billion, a 14% increase year-over-year.

Given its strong fundamentals and sizable content library, it could provide a strong value proposition as an acquisition target for streaming giants. Of course, buying VIAC stock because of rumors may not exactly be a great idea. However, should that really happen, it would make out nicely for existing shareholders.

The post Top Growth Stocks To Watch In June 2021 appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Government

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Submitted by Liam Cosgrove

Former…

Published

on

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Submitted by Liam Cosgrove

Former Project Veritas & O’Keefe Media Group operative and Pfizer formulation analyst scientist Justin Leslie revealed previously unpublished recordings showing Pfizer’s top vaccine researchers discussing major concerns surrounding COVID-19 vaccines. Leslie delivered these recordings to Veritas in late 2021, but they were never published:

Featured in Leslie’s footage is Kanwal Gill, a principal scientist at Pfizer. Gill was weary of MRNA technology given its long research history yet lack of approved commercial products. She called the vaccines “sneaky,” suggesting latent side effects could emerge in time.

Gill goes on to illustrate how the vaccine formulation process was dramatically rushed under the FDA’s Emergency Use Authorization and adds that profit incentives likely played a role:

"It’s going to affect my heart, and I’m going to die. And nobody’s talking about that."

Leslie recorded another colleague, Pfizer’s pharmaceutical formulation scientist Ramin Darvari, who raised the since-validated concern that repeat booster intake could damage the cardiovascular system:

None of these claims will be shocking to hear in 2024, but it is telling that high-level Pfizer researchers were discussing these topics in private while the company assured the public of “no serious safety concerns” upon the jab’s release:

Vaccine for Children is a Different Formulation

Leslie sent me a little-known FDA-Pfizer conference — a 7-hour Zoom meeting published in tandem with the approval of the vaccine for 5 – 11 year-olds — during which Pfizer’s vice presidents of vaccine research and development, Nicholas Warne and William Gruber, discussed a last-minute change to the vaccine’s “buffer” — from “PBS” to “Tris” — to improve its shelf life. For about 30 seconds of these 7 hours, Gruber acknowledged that the new formula was NOT the one used in clinical trials (emphasis mine):


“The studies were done using the same volume… but contained the PBS buffer. We obviously had extensive consultations with the FDA and it was determined that the clinical studies were not required because, again, the LNP and the MRNA are the same and the behavior — in terms of reactogenicity and efficacy — are expected to be the same.

According to Leslie, the tweaked “buffer” dramatically changed the temperature needed for storage: “Before they changed this last step of the formulation, the formula was to be kept at -80 degrees Celsius. After they changed the last step, we kept them at 2 to 8 degrees celsius,” Leslie told me.

The claims are backed up in the referenced video presentation:

I’m no vaccinologist but an 80-degree temperature delta — and a 5x shelf-life in a warmer climate — seems like a significant change that might warrant clinical trials before commercial release.

Despite this information technically being public, there has been virtually no media scrutiny or even coverage — and in fact, most were told the vaccine for children was the same formula but just a smaller dose — which is perhaps due to a combination of the information being buried within a 7-hour jargon-filled presentation and our media being totally dysfunctional.

Bohemian Grove?

Leslie’s 2-hour long documentary on his experience at both Pfizer and O’Keefe’s companies concludes on an interesting note: James O’Keefe attended an outing at the Bohemian Grove.

Leslie offers this photo of James’ Bohemian Grove “GATE” slip as evidence, left on his work desk atop a copy of his book, “American Muckraker”:

My thoughts on the Bohemian Grove: my good friend’s dad was its general manager for several decades. From what I have gathered through that connection, the Bohemian Grove is not some version of the Illuminati, at least not in the institutional sense.

Do powerful elites hangout there? Absolutely. Do they discuss their plans for the world while hanging out there? I’m sure it has happened. Do they have a weird ritual with a giant owl? Yep, Alex Jones showed that to the world.

My perspective is based on conversations with my friend and my belief that his father is not lying to him. I could be wrong and am open to evidence — like if boxer Ryan Garcia decides to produce evidence regarding his rape claims — and I do find it a bit strange the club would invite O’Keefe who is notorious for covertly filming, but Occam’s razor would lead me to believe the club is — as it was under my friend’s dad — run by boomer conservatives the extent of whose politics include disliking wokeness, immigration, and Biden (common subjects of O’Keefe’s work).

Therefore, I don’t find O’Keefe’s visit to the club indicative that he is some sort of Operation Mockingbird asset as Leslie tries to depict (however Mockingbird is a 100% legitimate conspiracy). I have also met James several times and even came close to joining OMG. While I disagreed with James on the significance of many of his stories — finding some to be overhyped and showy — I never doubted his conviction in them.

As for why Leslie’s story was squashed… all my sources told me it was to avoid jail time for Veritas executives.

Feel free to watch Leslie’s full documentary here and decide for yourself.

Fun fact — Justin Leslie was also the operative behind this mega-viral Project Veritas story where Pfizer’s director of R&D claimed the company was privately mutating COVID-19 behind closed doors:

Tyler Durden Tue, 03/12/2024 - 13:40

Read More

Continue Reading

International

Association of prenatal vitamins and metals with epigenetic aging at birth and in childhood

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging…

Published

on

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”

Credit: 2024 Bozack et al.

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”

BUFFALO, NY- March 12, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 4, entitled, “Associations of prenatal one-carbon metabolism nutrients and metals with epigenetic aging biomarkers at birth and in childhood in a US cohort.”

Epigenetic gestational age acceleration (EGAA) at birth and epigenetic age acceleration (EAA) in childhood may be biomarkers of the intrauterine environment. In this new study, researchers Anne K. Bozack, Sheryl L. Rifas-Shiman, Andrea A. Baccarelli, Robert O. Wright, Diane R. Gold, Emily Oken, Marie-France Hivert, and Andres Cardenas from Stanford University School of Medicine, Harvard Medical School, Harvard T.H. Chan School of Public Health, Columbia University, and Icahn School of Medicine at Mount Sinai investigated the extent to which first-trimester folate, B12, 5 essential and 7 non-essential metals in maternal circulation are associated with EGAA and EAA in early life. 

“[…] we hypothesized that OCM [one-carbon metabolism] nutrients and essential metals would be positively associated with EGAA and non-essential metals would be negatively associated with EGAA. We also investigated nonlinear associations and associations with mixtures of micronutrients and metals.”

Bohlin EGAA and Horvath pan-tissue and skin and blood EAA were calculated using DNA methylation measured in cord blood (N=351) and mid-childhood blood (N=326; median age = 7.7 years) in the Project Viva pre-birth cohort. A one standard deviation increase in individual essential metals (copper, manganese, and zinc) was associated with 0.94-1.2 weeks lower Horvath EAA at birth, and patterns of exposures identified by exploratory factor analysis suggested that a common source of essential metals was associated with Horvath EAA. The researchers also observed evidence of nonlinear associations of zinc with Bohlin EGAA, magnesium and lead with Horvath EAA, and cesium with skin and blood EAA at birth. Overall, associations at birth did not persist in mid-childhood; however, arsenic was associated with greater EAA at birth and in childhood. 

“Prenatal metals, including essential metals and arsenic, are associated with epigenetic aging in early life, which might be associated with future health.”

 

Read the full paper: DOI: https://doi.org/10.18632/aging.205602 

Corresponding Author: Andres Cardenas

Corresponding Email: andres.cardenas@stanford.edu 

Keywords: epigenetic age acceleration, metals, folate, B12, prenatal exposures

Click here to sign up for free Altmetric alerts about this article.

 

About Aging:

Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Facebook
  • X, formerly Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Reddit
  • Pinterest
  • Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1

###


Read More

Continue Reading

Trending